New Adventures in Science Publishing

Nearly a year ago, a group of high-profile scientists came together in hopes of sparking widespread reform throughout the science publishing industry.1 Although publishers certainly took notice, these scientists' efforts to establish a so-called Public Library of Science (PLOS) have fallen well short of initial objectives. PLOS founders have now decided to maintain their principles but change their strategy by launching a freely accessible, author fee-funded, peer reviewed online journal. In a

Written byEugene Russo
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In an open letter first circulated nearly a year ago, founding members of the PLOS demanded that publishers make all content freely available six months after initial publication without restrictions. The idea was to not only eliminate often-prohibitive subscription fees, but to make all published scientific literature fully searchable via large repositories. Publishers who didn't comply by this past September faced a potential boycott from the tens of thousands of scientists from all over the world who signed on to the initiative (Signatures on the PLOS Web site currently total more than 28,000). Although science publishers certainly took notice, leading to varying degrees of cooperation, few journals have explicitly complied with PLOS demands. Several publishers called the PLOS effort too aggressive, financially unrealistic, and an avenue toward the unwarranted and unwelcome loss of control of their own operations.

"The Public Library of Science has actually been a big success despite ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies